| 000 | 00781nam a22002297a 4500 | ||
|---|---|---|---|
| 003 | BUL | ||
| 005 | 20230403121957.0 | ||
| 008 | 190615b xxu||||| |||| 00| 0 eng d | ||
| 020 |
_a9780702070297 _cRs.2879/- |
||
| 040 | _aBUL | ||
| 082 |
_a615.1901 _bWAT'P17 |
||
| 100 | _aWatson, David G. | ||
| 245 |
_aPharmaceutical analysis _cDavid G. Watson ; with contributions by RuAngelie Edrada-Ebel, Bhavik A. Patel |
||
| 250 | _a4th ed | ||
| 260 |
_aEdinburgh _bElsevier _cc2017 |
||
| 300 | _axv, 461p. | ||
| 650 |
_a Microbial contamination _vPharmaceutical Analysis & Quality Assurance |
||
| 650 |
_a Pharmaceutical technology _vQuality control _xPharmaceutical Analysis & Quality Assurance |
||
| 650 |
_aCosmetics _vMicrobiology |
||
| 650 |
_aDrugs _vMicrobiology |
||
| 942 | _cBOOK | ||
| 999 |
_c3156 _d3156 |
||